This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Centre Hospitalier Universitaire Grenoble Alpes, National Institute of Health and Medical Research, Université Grenoble Alpes. Active years: 2020.
Company Filing History:
1 out of 10 
1 out of 1,853 
1 out of 177 
Years Active: 2020
Title: Pascale Perret: Innovator in Anti-Tau Nanobodies
Introduction
Pascale Perret is a notable inventor based in La Tronche, France. He has made significant contributions to the field of biomedical research, particularly in the development of anti-Tau nanobodies. His work is crucial in understanding and potentially treating neurodegenerative diseases.
Latest Patents
Pascale Perret holds a patent for his invention titled "Anti-Tau Nanobodies." This invention relates to the creation of nanobodies that target the Tau protein, which is implicated in various neurodegenerative conditions. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Throughout his career, Pascale has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université Grenoble Alpes. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Pascale has collaborated with notable colleagues, including Sabine Chierici and Marcelle Moulin. These partnerships have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Pascale Perret's work in developing anti-Tau nanobodies represents a significant advancement in biomedical research. His contributions are vital for future innovations in treating neurodegenerative diseases.